RecallHawk

RHUZDAH (NORETHINDRONE AND ETHINYL ESTRADIOL TABLET)

AUROBINDO PHARMA

Summary

FDA approved RHUZDAH (NORETHINDRONE AND ETHINYL ESTRADIOL TABLET) by AUROBINDO PHARMA. ANDA (Generic) approval on 2022-10-11. TABLET, ORAL-28.

Details

Source

Drug Approval

External ID

ANDA207585-1

Action Date

2022-10-11

Status

Approved

Category

drug

Product Code

ANDA (Generic)

Product Description

RHUZDAH (generic: NORETHINDRONE AND ETHINYL ESTRADIOL TABLET), TABLET, ORAL-28. Application: ANDA207585

Context & Analysis

AUROBINDO PHARMA has 76 FDA actions in our database.

Frequently Asked Questions

How often does AUROBINDO PHARMA have FDA actions?

AUROBINDO PHARMA has 76 FDA actions in our database, including 0 recalls and 0 device clearances.

Where can I find the official FDA record?

The official record is available on FDA.gov. Search for "ANDA207585-1" on FDA.gov for the full record. You can also use the openFDA API to query this record programmatically.

Want to know the moment something like this happens?

Get alerts for drug

Related Actions